Similar articles

• Benzalkonium chloride in glaucoma medications.

  Noecker R, Miller KV. Noecker R, et al. Ocul Surf. 2011 Jul;9(3):159-62. doi: 10.1016/s1542-0124(11)70025-8. Ocul Surf. 2011. PMID: 21791190 Review.
• Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma.

  Baudouin C. Baudouin C. Acta Ophthalmol. 2008 Nov;86(7):716-26. doi: 10.1111/j.1755-3768.2008.01250.x. Epub 2008 Jun 3. Acta Ophthalmol. 2008. PMID: 18537937 Review.
• [Optimization of benzalkonium chloride concentration in 0.0015% tafluprost ophthalmic solution from the points of ocular surface safety and preservative efficacy].

  Asada H, Takaoka-Shichijo Y, Nakamura M, Kimura A. Asada H, et al. Yakugaku Zasshi. 2010 Jun;130(6):867-71. doi: 10.1248/yakushi.130.867. Yakugaku Zasshi. 2010. PMID: 20519865 Japanese.
• Effects of common ophthalmic preservatives on ocular health.

  Noecker R. Noecker R. Adv Ther. 2001 Sep-Oct;18(5):205-15. doi: 10.1007/BF02853166. Adv Ther. 2001. PMID: 11783457 Review.
• [Corneal sensitivity in patients treated medically for glaucoma or ocular hypertension].

  Van Went C, Alalwani H, Brasnu E, Pham J, Hamard P, Baudouin C, Labbé A. Van Went C, et al. J Fr Ophtalmol. 2011 Dec;34(10):684-90. doi: 10.1016/j.jfo.2011.07.011. Epub 2011 Nov 16. J Fr Ophtalmol. 2011. PMID: 22093372 French.